source
- Early Alert: Nitric Oxide Delivery System Issue from NOxBOXThe NOxBOX NOxBOXi System may leak oxygen during inhaled nitric oxide therapy
- Scribe Therapeutics’ early-stage IPO surges 43% as epigenetic cholesterol drug enters clinicScribe Therapeutics filed for an IPO while its lead epigenetic therapy moves into early clinical testing, a rare combination in a market that prefers later-stage, de-risked offerings. The company…